Oxfam’s damning report puts multinational pharma companies in the dock over tax evasion
Tax Dodgers: In seven developing countries, firms appeared to avoid an estimated $112m in taxes every year
ISLAMABAD: Oxfam International’s damning report confirmed...
PSW, DRAP launch digital certificates to boost pharmaceutical exports
Alongside Digital Certificate of Pharmaceutical Product, DRAP Clearance Gateway now offers Free Sale Certificate, Good Manufacturing Practice Certificate, and No Objection Certificate for exports; initiative to enhance regulatory efficiency
Govt backs PPMA’s expansion plans, discusses roadmap for $3 billion pharma export target by 2028
PharmEx Pakistan platform set to drive pharmaceutical exports to $3 billion in three years, and $10 billion over the next five years
LCCI demands DRAP to form a liaison committee
LAHORE: The Lahore Chamber of Commerce and Industry (LCCI) has demanded from the Drug Regulatory Authority of Pakistan (DRAP) to form a...
Searle Company to divest entire stake in Searle Pakistan Limited
Board approves disposal of 100% shareholding; negotiations for terms underway
Citi Pharma partners with Mersi Farma to establish advanced API plants in Indonesia
Collaboration to bolster pharmaceutical production and expand nutraceutical market
Liven Pharmaceuticals just made a rights issue. Will this prove to be the last throw of the dice?
The pharmaceutical company has had a torrid history. The new development could prove to be its redemption
Citi Pharma completes first export to MENA region, targets EUR 10 million in annual global sales
Finalizes EUR 560,000 shipment; aims to expand exports to North America and beyond
GSK set to capitalise as Reckitt Benckiser pulls out of Pfizer deal
NEW YORK: British consumer goods group Reckitt Benckiser has pulled out of discussions with Pfizer over buying its consumer healthcare business, strengthening the...
Customs seizes smuggled Indian-origin medicines worth Rs10.3bn in Karachi
Investigation launched against two pharmaceutical companies over illegal drug trade
Pakistan’s retail pharma sector surpasses Rs1.049 trillion in sales
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
DRAP orders urgent recall of substandard medicines, medical products
Contaminated injections, syrups, and IV cannulas flagged; crackdown launched nationwide
Amoxil recall hits GSK Pakistan revenue in otherwise strong year
Deregulated drug pricing allowed the company to improve gross margins, but the recall still caused revenue to decline
Pharma has potential to surpass textile industry in Pakistan: Chairman AGP
KARACHI: The pharmaceutical industry in Pakistan has the potential to increase its exports to such an extent that it can become the biggest...
AGP acquires portfolio of products from American pharma firm Viatris
AGP claims newly acquired products will add Rs20b to annual revenues